Associate Director, New Product Planning

The Genesis New Product Planning (NPP) team drives decisions on Genesis's drug discovery & development program and portfolio strategy, and brings the commercial voice to these decisions through market analysis and engagement with external stakeholders. NPP drives cross-functional efforts to shape our products to meet the needs of patients, and works to find the best path forward to commercialize our innovations.

The Associate Director, New Product Planning is a high profile, high impact role. The successful candidate will combine their background in the life sciences, familiarity with drug discovery, and strong business acumen to drive strategic planning for AI-discovered programs at all stages of discovery and development, from new target nomination through clinical development. This person will engage on an ongoing basis with our C-suite, therapeutic area leads, and will also provide regular support to Corporate Strategy and Business Development initiatives.

This role will be based at Genesis Therapeutics’ physical office in San Diego.

Key Responsibilities:

• Guide program strategy and decision-making at all stages of discovery and clinical development
• Support portfolio strategy and analytics initiatives to enable prioritization & resource allocation
• Drive cross-functional new target nomination process, ensuring a thorough evaluation of strategic, scientific, and commercial considerations
• Steward technical diligence of new targets through conducting literature reviews and moderating KOL interviews
• Proactively identify and pursue opportunities for providing commercial input to improve strategy and decision making
• Conduct primary and secondary research to assess the commercial attractiveness of new preclinical product opportunities including market sizing, target product profile development, and competitive assessment.
• Maintain highly detailed tracking of preclinical and clinical competitive programs.
• Sit on Genesis’ preclinical and early clinical stage development teams as the commercial representative and provide expert guidance to the team on commercial and market considerations.
• Support the implementation and improvement of processes, capabilities, and templates to augment the NPP team’s impact, e.g. disease opportunity assessment templates, TPP templates, competitive tracking alerts, etc.
• Provide commercial support to Business Development and Corporate Strategy initiatives.
• Closely collaborate with our Program Management, Finance and FP&A teams to support detailed planning and budgeting.

The ideal candidate will have:

• A strong understanding of drug discovery, including typical workflows, experiments, and tools, as demonstrated through a combination of previous hands-on experience in a discovery organization, and a life sciences PhD
• Experience planning and executing commercial assessments based on primary and secondary research for pre-clinical and early clinical (P1-P2) assets
• The ability to digest complex biological concepts, and distill credible and clear recommendations to a broad set of senior stakeholders
• The ability to interpret clinical data and communicate key insights relevant to our internal programs
• Familiarity with life sciences industry trends in R&D and commercialization (e.g. emerging technologies and drug targets)

Required experience:

• PhD in a relevant Life Sciences discipline (e.g. biology, biochemistry / molecular biology, pharmacology, etc.)
• At least 6 years of professional experience, with 4 years in a New Product Planning / Marketing role within a pharmaceutical or biotech company, a biotech venture capital firm, or a strategy consulting firm that provides services to life sciences companies
• Experience with typical tools, data sources, and market research methods used in biopharma commercial planning
• Strong Excel modeling and Powerpoint skills
• Excellent communication, listening and strong presentation skills
• Ability to travel domestically and internationally, if required, approximately 10% of the time - potentially more if working remotely.

Genesis Therapeutics is unifying AI and biotech to discover novel and breakthrough treatments for patients with severe and devastating conditions. Genesis was founded on groundbreaking molecular ML research and since has established itself as the industry leader in AI for small molecule drug discovery. Our team of accomplished biotech leaders and expert drug hunters joins forces with deep learning researchers and software engineers who are pioneering predictive and generative AI technologies for molecules.

Our team has created the industry's most advanced molecular AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery and to enable the discovery of novel first-in-class and best-in-class small molecule drugs for challenging and/or undruggable targets. 

The company has leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has three AI platform collaborations across a range of therapeutic areas, with Gilead Sciences, Eli Lilly, and Genentech.

We raised a $200M series B in August 2023, and have raised over $300M in funding from top technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures. 

Genesis is headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego. We are proud to be an inclusive workplace and an Equal Opportunity Employer.